Net profit of Mankind Pharma declined 16.20% to Rs 380.23 crore in the quarter ended December 2024 as against Rs 453.76 crore during the previous quarter ended December 2023. Sales rose 23.90% to Rs 3230.00 crore in the quarter ended December 2024 as against Rs 2606.95 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended |
| Dec. 2024 | Dec. 2023 | % Var. |
| Sales | 3230.00 | 2606.95 | 24 |
| OPM % | 25.69 | 23.26 | - |
| PBDT | 689.63 | 672.04 | 3 |
| PBT | 497.33 | 562.32 | -12 |
| NP | 380.23 | 453.76 | -16 |